日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer.

MUCIN 1 赋予非小细胞肺癌对酪氨酸激酶抑制剂耐药性的炎症记忆。

Takamori Shinkichi, Haratake Naoki, Bhattacharya Atrayee, Kikutake Chie, Ozawa Hiroki, Shigeta Keisuke, Nakashoji Ayako, Isozaki Hideko, Shimokawa Mototsugu, Suyama Mikita, Hashinokuchi Asato, Takada Kazuki, Toyokawa Gouji, Yamada Yuichi, Takenaka Tomoyoshi, Taguchi Kenichi, Yamaguchi Masafumi, Yoshizumi Tomoharu, Hata Aaron N, Kufe Donald

Identifying Key Variances in Clinical Pathways Associated With Prolonged Hospital Stays Using Machine Learning and ePath Real-World Data: Model Development and Validation Study

利用机器学习和ePath真实世界数据识别与住院时间延长相关的临床路径关键差异:模型开发与验证研究

Tou, Saori; Matsumoto, Koutarou; Hashinokuchi, Asato; Kinoshita, Fumihiko; Nohara, Yasunobu; Yamashita, Takanori; Wakata, Yoshifumi; Takenaka, Tomoyoshi; Soejima, Hidehisa; Yoshizumi, Tomoharu; Nakashima, Naoki; Kamouchi, Masahiro

Lack of Survival Benefit with Immunotherapy in Combination with Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-small Cell Lung Cancer

免疫疗法联合辅助放化疗治疗病理分期为II-IIIB期的非小细胞肺癌未显示出生存获益

Venugopal, Natasha; Vazquez-Urrutia, Jorge Raul; Zhu, Junjia; Hashinokuchi, Asato; Takamori, Shinkichi; Komiya, Takefumi

ASO Author Reflections: Examining the Outcomes of Adding Immunotherapy to Adjuvant Chemoradiation in Pathologic Stage II-IIIB Non-Small Cell Lung Cancer

ASO作者反思:探讨在病理分期为II-IIIB期的非小细胞肺癌辅助放化疗中加入免疫疗法的疗效

Venugopal, Natasha; Vazquez-Urrutia, Jorge Raul; Zhu, Junjia; Hashinokuchi, Asato; Takamori, Shinkichi; Komiya, Takefumi

Adaptation to acidic conditions that mimic the tumor microenvironment, downregulates miR-193b-3p, and induces EMT via TGFβ2 in A549 cells

A549细胞适应模拟肿瘤微环境的酸性条件后,miR-193b-3p表达下调,并通过TGFβ2诱导EMT。

Higashi, Sadayuki; Yamakuchi, Munekazu; Hashinokuchi, Hirohito; Takenouchi, Kazunori; Tabaru, Akito; Oyama, Yoko; Fujisaki, Chieko; Tanoue, Kiyonori; Hashiguchi, Teruto

Reply to Dr Hooda Z

回复胡达博士

Hashinokuchi, Asato; Akamine, Takaki; Takenaka, Tomoyoshi; Yoshizumi, Tomoharu

Narrative review of the prognostic significance of primary tumor size in thymic epithelial tumor

胸腺上皮肿瘤原发肿瘤大小预后意义的叙述性综述

Hashinokuchi, Asato; Takamori, Shinkichi; Takenaka, Tomoyoshi; Yoshizumi, Tomoharu; Komiya, Takefumi

Data-driven prediction of prolonged air leak after video-assisted thoracoscopic surgery for lung cancer: Development and validation of machine-learning-based models using real-world data through the ePath system

基于数据驱动的肺癌胸腔镜手术后持续性漏气预测:利用ePath系统,通过真实世界数据开发和验证基于机器学习的模型

Tou, Saori; Matsumoto, Koutarou; Hashinokuchi, Asato; Kinoshita, Fumihiko; Nakaguma, Hideki; Kozuma, Yukio; Sugeta, Rui; Nohara, Yasunobu; Yamashita, Takanori; Wakata, Yoshifumi; Takenaka, Tomoyoshi; Iwatani, Kazunori; Soejima, Hidehisa; Yoshizumi, Tomoharu; Nakashima, Naoki; Kamouchi, Masahiro

MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC

MUC1-C 是 NSCLC 获得性奥希替尼耐药的常见驱动因素

Naoki Haratake, Hiroki Ozawa, Yoshihiro Morimoto, Nami Yamashita, Tatsuaki Daimon, Atrayee Bhattacharya, Keyi Wang, Ayako Nakashoji, Hideko Isozaki, Mototsugu Shimokawa, Chie Kikutake, Mikita Suyama, Asato Hashinokuchi, Kazuki Takada, Tomoyoshi Takenaka, Tomoharu Yoshizumi, Tetsuya Mitsudomi, Aaron

The Clinical Role of Adjuvant Chemotherapy after Sublobar Resection for Non-Small-Cell Lung Cancer ≤ 20 mm with Lymph Node Metastases: A Propensity-Matched Analysis of the National Cancer Database

非小细胞肺癌(≤20 mm,伴淋巴结转移)亚肺叶切除术后辅助化疗的临床作用:基于国家癌症数据库的倾向性匹配分析

Takamori, Shinkichi; Zhu, Junjia; Hashinokuchi, Asato; Komiya, Takefumi